Evidence map›Paper›PMID 26130668›Full record

ArticleCancer research and treatment2016

Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer.

Jungnam Joo, Kyong-Ah Yoon, Tomonori Hayashi, Sun-Young Kong, Hye-Jin Shin, Boram Park, Young Min Kim, Sang-Hyun Hwang, Jeongseon Kim, Aesun Shin and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer research and treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. International journal of molecular epidemiology and genetics · 2018
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Jungnam JooBiometric Research Branch, National Cancer Center, Goyang, Korea.
Kyong-Ah YoonLung Cancer Branch, National Cancer Center, Goyang, Korea.
Tomonori HayashiDepartment of Radiobiology and Molecular Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
Sun-Young KongTranslational Epidemiology Research Branch and Department of Laboratory Medicine, National Cancer Center, Goyang, Korea.
Hye-Jin ShinRadiation Medicine Branch, National Cancer Center, Goyang, Korea.
Boram ParkBiometric Research Branch, National Cancer Center, Goyang, Korea.
Young Min KimDepartment of Statistics, Radiation Effects Research Foundation, Hiroshima, Japan.
Sang-Hyun HwangHematologic Malignancy Branch and Department of Laboratory Medicine, National Cancer Center, Goyang, Korea.
Jeongseon KimMolecular Epidemiology Branch, National Cancer Center, Goyang, Korea.
Aesun ShinMolecular Epidemiology Branch, National Cancer Center, Goyang, Korea.
Joo-Young KimRadiation Medicine Branch, National Cancer Center, Goyang, Korea.
National Cancer Center · KRNational Cancer Center · USRadiation Effects Research Foundation · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDefects in the DNA damage repair process can cause genomic instability and play an important role in cervical carcinogenesis. The purpose of this study was to analyze the association of 29 candidate single nucleotide polymorphisms (SNPs) in genes in the DNA repair pathway, TP53, and TP53BP1 with the risk of cervical cancer. MATERIALS AND

methodsTwenty-nine SNPs in four genes in the DNA repair pathway (ERCC2, ERCC5, NBS1, and XRCC1), TP53, and TP53BP1 were genotyped for 478 cervical cancer patients and 922 healthy control subjects, and their effects on cervical carcinogenesis were analyzed.

resultsThe most significant association was found for rs17655 in ERCC5, with an age-adjusted p-value < 0.0001, for which a strong additive effect of the risk allele C was observed (odds ratio, 2.01 for CC to GG). On the other hand, another significant polymorphism rs454421 in ERCC2 showed a dominant effect (odds ratio, 1.68 for GA+AA to GG) with an age-adjusted p-value of 0.0009. The association of these polymorphisms remained significant regardless of the age of onset. The significant result for rs17655 was also consistent for subgroups of patients defined by histology and human papillomavirus (HPV) types. However, for rs454421, the association was observed only in patients with squamous cell carcinoma and non-HPV 18 type.

conclusionThe results of this study show a novel association of cervical cancer and the genes involved in the nucleotide excision pathway in the Korean population.

Indexed as

DNA-Binding ProteinsDNA Excision Repair Protein ERCC-5DNA RepairEndonucleasesFemaleGenetic Predisposition to DiseaseHumansNuclear ProteinsPolymorphism, Single NucleotideTranscription FactorsUterine Cervical NeoplasmsXeroderma Pigmentosum Group D ProteinDNA-Binding ProteinsDNA Excision Repair Protein ERCC-5EndonucleasesERCC2 protein, humanNuclear ProteinsTranscription FactorsXeroderma Pigmentosum Group D ProteinERCCSingle nucleotide polymorphismUterine cervical neoplasms

Identifiers

PMID26130668
PMCPMC4843739
OpenAlexW2151045583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.